Transgene Biotek Limited (BOM:526139)
India flag India · Delayed Price · Currency is INR
2.880
+0.010 (0.35%)
At close: Apr 28, 2026

Transgene Biotek Company Description

Transgene Biotek Limited, a biotechnology company, provides research and development services for bulk drugs in India.

It offers a portfolio of oncology drugs, oral drug delivery, and biogenerics. The company provides TrabiDHA for use in health food, baby food/formula, health supplement, and chicken and animal feed markets; Tacrolimus, a drug that suppresses the immune system and is used to prevent rejection of transplanted organs; and Orlistat (tetrahydrolipstatin), a lipase inhibitor that blocks about one-third of intestinal fat absorption.

The company was incorporated in 1990 and is based in Sangareddy, India.

Transgene Biotek Limited
Country India
Founded 1990
Industry Biological Products, Except Diagnostic Substances
CEO Koteswara Kanuru

Contact Details

Address:
Plot No. 69 & 70
Sangareddy, 502325
India
Phone 91 40 6558 9499
Website transgenebiotek.com

Stock Details

Ticker Symbol 526139
Exchange Bombay Stock Exchange
Fiscal Year April - March
Reporting Currency INR
SIC Code 2836

Key Executives

Name Position
Koteswara Kanuru Chief Executive Officer
Chowdari Prasad Chief Financial Officer